Want more claimants? Fill out the form to get free info.
    By submitting this form, I consent that I may be contacted by email and/or phone (including a wireless number) using automated technology, by Adwire Media and/or third-party partners. If I have provided my cell number I also acknowledge that I may be contacted via text message. Message and data rates may apply. My consent is not a requirement for receipt of services.*

    Valsartan Criteria

    The criteria below is a list of standard filters. We can customize the criteria based on your requirements.
    • Took any of the following blood pressure medications after Jan 1, 2014
      • valsartan (Diovan & Prexxartan)
      • aliskiren + valsartan (Valturna)
      • amlodipine + valsartan (Exforge)
      • nebivolol + valsartan (Byvalson)
      • sacubitril + valsartan (Entresto)
      • losartan (Cozaar)
      • irbesartan (Avapro)
    • Diagnosed with one of the following cancers while on the medication
      • Liver cancer
      • Gastric cancer
      • Esophageal cancer
      • Stomach cancer
      • Colon cancer
      • Colorectal cancer
      • Kidney cancer
      • Intestinal cancer
      • Anal cancer
      • Pancreatic cancer
      • Gallbladder cancer
      • Other digestive tract cancer
    • Not diagnosed with cancer prior to Valsartan use
    • No legal representation

    Valsartan Background Information


    Diovan, Valturna, Exforge, Byvalson, Entresto, Cozaar, Avapro


    Teva Pharmaceuticals, Torent Pharmaceuticals, Prinston Pharmaceuticals, Solco Healthcare, Major Pharmaceuticals, Actavis, A-s Medication Solutions, AvKARE, NuCare Pharmaceuticals, Bryant Ranch Repack, Northwind Pharmaceuticals, RemedyRepack, Camber Pharmaceuticals


    Valsartan and other generic angiotensin II receptor blockers (ARB’s), which are used to treat hypertension (which effects 1 in 3 Americans) have been found to be contaminated with an impurity called NNitrosodimehtylamine (NDMA). NDMA is a well-known carcinogen and exposure to such leads to significant risk of liver cancer, liver failure, stomach cancer, colorectal cancer, bowel cancer, and kidney cancer.

    FDA Warning

    July 13, 2018 FDA issues its largest Class 1 Recall ever. More that 2,000,000 Americans received a recall letter due to the possible NDMA contamination of their generic valsartan ARB. There have been numerous follow-on recalls by the FDA as well as similar associated announcements by the WHO, Health Canada, European Medical Association (EMA), Hong Kong Dept. of Health


    No current MDL. Plaintiff firms has filed for centralization in the District of New Jersey, requesting US District Court Judge, Freda Wolfson, to preside over the matter if the JPML grants consolidation. Judge Wolfson is currently overseeing MDL #2738, a consolidation of talcum powder claimants.


    We welcome you to contact Mass Torts USA for more information
    about our products and services.